ArriVent BioPharma, Inc. Quarterly Common Stock, Shares Authorized from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
ArriVent BioPharma, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2023 to Q3 2024.
  • ArriVent BioPharma, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 200M shares.
Common Stock, Shares Authorized, Quarterly (shares)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 200M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 200M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 200M Mar 31, 2024 10-Q 2024-05-08
Q4 2023 200M Dec 31, 2023 10-Q 2024-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.